Facing pressure from lawmakers about the prices of their drugs, some pharmaceutical companies are looking for ways to make their products more affordable and more accessible.
Novo Nordisk (NYSE:NVO) said yesterday that it is teaming up with CVS Health‘s (NYSE:CVS) new prescription savings program, Reduced Rx, to offer discounts on its insulin. The company’s insulin will be sold for $25 per 10 milliliter vial, which Nordisk said reflects a savings of as much as $100 for patients that pay with cash.
Get the full story at our sister site, Drug Delivery Business News.